Dianhui Tan
YOU?
Author Swipe
View article: DNA N6-methyladenine modifications of Acidithiobacillus ferrooxidans response to copper stress
DNA N6-methyladenine modifications of Acidithiobacillus ferrooxidans response to copper stress Open
High concentrations of copper ions have long been recognized as a key factor limiting the efficiency of bioleaching due to the metal toxicity to microorganisms. In order to identify new determinants of copper resistance, we assessed the im…
View article: Prevalence, risk factors, prediction of robust callus formation and accelerated fracture healing in traumatic brain injury patients: a five-year study
Prevalence, risk factors, prediction of robust callus formation and accelerated fracture healing in traumatic brain injury patients: a five-year study Open
The findings from this study offer crucial insights to enhance clinical decision-making and treatment approaches for managing fractures in TBI patients. Furthermore, our research establishes a groundwork for future investigations into the …
View article: J-shaped associations of pan-immune-inflammation value and systemic inflammation response index with stroke among American adults with hypertension: evidence from NHANES 1999–2020
J-shaped associations of pan-immune-inflammation value and systemic inflammation response index with stroke among American adults with hypertension: evidence from NHANES 1999–2020 Open
Introduction Stroke, a leading cause of death and disability worldwide, is primarily ischemic and linked to hypertension. Hypertension, characterized by systemic chronic inflammation, significantly increases stroke risk. This study explore…
View article: Establishment of a model to predict mortality after decompression craniotomy for traumatic brain injury
Establishment of a model to predict mortality after decompression craniotomy for traumatic brain injury Open
Background The mortality rate of patients with traumatic brain injury (TBI) is still high even while undergoing decompressive craniectomy (DC), and the expensive treatment costs bring huge economic burden to the families of patients. Objec…
View article: Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients
Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients Open
Summary Background In the large randomised NEPTUNE study, peginterferon alfa‐2a 180 μg/wk for 48 weeks produced higher hepatitis B e antigen ( HB eAg) seroconversion rates 24 weeks post‐treatment (36%) than a lower dose (90 μg/wk) and/or s…